Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125755) titled 'Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma' on Aug. 10.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Care Provider, Outcomes Assessor).

Primary Sponsor: Sun Yat-sen University

Condition: Squamous Cell Cancer of Head and Neck (SCCHN)

Intervention: Drug: Cisplatin

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: August 15, 2025

Target Sample Size: 386

Co...